About

Mark Edbrooke, PhD, Head of Strategy at N4 Pharma, is an independent scientific consultant with broad experience in pharmaceutical R&D. During 25 years at GSK, he ran a transnational functional genomics department, then set up and led GSK’s therapeutic nucleic acid unit. Dr Edbrooke then joined AstraZeneca’s Oncology Division for three years, working with Ionis and Moderna.

He currently has a portfolio of clients including UK- and US-based investment companies, UK- and European-based universities, and small biotech companies including being Head of Translational Research at Argonaute RNA and on the scientific advisory board for Deep Genomics.